Navigation Links
Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009
Date:5/11/2009

CRANBURY, N.J., May 11 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company's Chief Operating Officer, Matthew R. Patterson, will be presenting at the upcoming Bank of America and Merrill Lynch Conference in New York City. Mr. Patterson's presentation is scheduled to begin on Wednesday, May 13th at 4:00 p.m. EDT.

Individuals can listen to a live webcast of the presentation by logging on to the Investors section of the Amicus Therapeutics' Web site, http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's Web site for 30 days.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs.


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
2. Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
3. Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting
4. Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
5. Amicus Therapeutics Announces Change to Board of Directors
6. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
7. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
8. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
9. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
10. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
11. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... PUNE, India , Jan. 18, 2017  Market Research Future ... Cancer Diagnostics Market is expected to grow at a CAGR of ... Highlights ... a disease caused due to the abnormal cell division without any ... and cause harm to them. These cancer cells can spread to ...
(Date:1/17/2017)... ... January 17, 2017 , ... MS Technologies™ and Bayer have ... Soybean Performance System will combine industry-leading genetics with a double herbicide-tolerant trait that ... Balance® Bean herbicide. The Balance™ GT Soybean Performance System will benefit soybean growers ...
(Date:1/17/2017)... 2017  An international team of researchers from ... Boniface Hospital Albrechtsen Research Centre/University of Manitoba have ... health need affecting nearly one in 15 Americans. ... their results identify small molecule drugs with neuroprotective ... injury in animal models of metabolic, chemical and ...
(Date:1/17/2017)... , Jan. 17, 2017  Zimmer Biomet Holdings, Inc. ... and full-year 2016 sales and earnings conference call will ... 31, 2017, at 8 a.m. Eastern Time.  A news ... made available at 7:30 a.m. Eastern Time the morning ... webcast can be accessed via Zimmer Biomet,s Investor Relations ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
(Date:12/15/2016)... Dec. 15, 2016  There is much more to ... starting the engine. Continental will demonstrate the intelligence of ... Vegas . Through the combination of the keyless ... and biometric elements, the international technology company is opening ... and authentication. "The integration of biometric elements ...
Breaking Biology News(10 mins):